The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Age-related Macular Degeneration-Global Market Insights and Sales Trends 2025
Synopsis
The global Age-related Macular Degeneration market size is expected to reach US$ 11400 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Age-related Macular Degeneration in various end use industries. The expanding demands from the Drugstore, Hospital and Others,, are propelling Age-related Macular Degeneration market. Wet AMD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry AMD segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Age-related Macular Degeneration market, driven by demand from China, the second largest economy with some signs of stabilising, the Age-related Macular Degeneration market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Age-related Macular Degeneration, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Age-related Macular Degeneration market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Age-related Macular Degeneration market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Age-related Macular Degeneration sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Age-related Macular Degeneration covered in this report include Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb and Gilead Sciences, etc.
The global Age-related Macular Degeneration market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Global Age-related Macular Degeneration market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Age-related Macular Degeneration market, Segment by Type:
Wet AMD
Dry AMD
Global Age-related Macular Degeneration market, by Application
Drugstore
Hospital
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Age-related Macular Degeneration companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
The global Age-related Macular Degeneration market size is expected to reach US$ 11400 million by 2029, growing at a CAGR of 5.8% from 2023 to 2029. The market is mainly driven by the significant applications of Age-related Macular Degeneration in various end use industries. The expanding demands from the Drugstore, Hospital and Others,, are propelling Age-related Macular Degeneration market. Wet AMD, one of the segments analysed in this report, is projected to record % CAGR and reach US$ million by the end of the analysis period. Growth in the Dry AMD segment is estimated at % CAGR for the next seven-year period.
Asia Pacific shows high growth potential for Age-related Macular Degeneration market, driven by demand from China, the second largest economy with some signs of stabilising, the Age-related Macular Degeneration market in China is forecast to reach US$ million by 2029, trailing a CAGR of % over the 2023-2029 period, while the U.S. market will reach US$ million by 2029, exhibiting a CAGR of % during the same period.
Report Objectives
This report provides market insight on the different segments, by players, by Type, by Application. Market size and forecast (2018-2029) has been provided in the report. The primary objectives of this report are to provide 1) global market size and forecasts, growth rates, market dynamics, industry structure and developments, market situation, trends; 2) global market share and ranking by company; 3) comprehensive presentation of the global market for Age-related Macular Degeneration, with both quantitative and qualitative analysis through detailed segmentation; 4) detailed value chain analysis and review of growth factors essential for the existing market players and new entrants; 5) emerging opportunities in the market and the future impact of major drivers and restraints of the market.
Key Features of The Study:
This report provides in-depth analysis of the global Age-related Macular Degeneration market, and provides market size (US$ million) and CAGR for the forecast period (2023-2029), considering 2022 as the base year.
This report profiles key players in the global Age-related Macular Degeneration market based on the following parameters - company details (found date, headquarters, manufacturing bases), products portfolio, Age-related Macular Degeneration sales data, market share and ranking.
This report elucidates potential market opportunities across different segments and explains attractive investment proposition matrices for this market.
This report illustrates key insights about market drivers, restraints, opportunities, market trends, regional outlook.
Key companies of Age-related Macular Degeneration covered in this report include Bayer HealthCare, F. Hoffmann-La Roche, Novartis, Regeneron Pharmaceuticals, Alcon, Allergan, Avalanche, Bausch+Lomb and Gilead Sciences, etc.
The global Age-related Macular Degeneration market report caters to various stakeholders in this industry including investors, suppliers, product players, distributors, new entrants, and financial analysts.
Market Segmentation
Company Profiles:
Bayer HealthCare
F. Hoffmann-La Roche
Novartis
Regeneron Pharmaceuticals
Alcon
Allergan
Avalanche
Bausch+Lomb
Gilead Sciences
Iconic Therapeutics
Neurotech Pharmaceuticals
Ohr Pharmaceutical
Global Age-related Macular Degeneration market, by region:
North America (U.S., Canada, Mexico)
Europe (Germany, France, UK, Italy, etc.)
Asia Pacific (China, Japan, South Korea, Southeast Asia, India, etc.)
South America (Brazil, etc.)
Middle East and Africa (Turkey, GCC Countries, Africa, etc.)
Global Age-related Macular Degeneration market, Segment by Type:
Wet AMD
Dry AMD
Global Age-related Macular Degeneration market, by Application
Drugstore
Hospital
Others
Core Chapters
Chapter One: Introduces the report scope of the report, executive summary of global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2029). It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter Two: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter Three: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter Four: Detailed analysis of Age-related Macular Degeneration companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter Five: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product introduction, revenue, recent development, etc.
Chapter Six, Seven, Eight, Nine and Ten: North America, Europe, Asia Pacific, Latin America, Middle East & Africa, revenue by country.
Chapter Eleven: this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.
Chapter Twelve: Research Finding/Conclusion
Index1 Market Overview of Age-related Macular Degeneration
1.1 Age-related Macular Degeneration Market Overview
1.1.1 Age-related Macular Degeneration Product Scope
1.1.2 Age-related Macular Degeneration Market Status and Outlook
1.2 Global Age-related Macular Degeneration Market Size Overview by Region 2018 VS 2022 VS 2029
1.3 Global Age-related Macular Degeneration Market Size by Region (2018-2029)
1.4 Global Age-related Macular Degeneration Historic Market Size by Region (2018-2023)
1.5 Global Age-related Macular Degeneration Market Size Forecast by Region (2024-2029)
1.6 Key Regions, Age-related Macular Degeneration Market Size (2018-2029)
1.6.1 North America Age-related Macular Degeneration Market Size (2018-2029)
1.6.2 Europe Age-related Macular Degeneration Market Size (2018-2029)
1.6.3 Asia-Pacific Age-related Macular Degeneration Market Size (2018-2029)
1.6.4 Latin America Age-related Macular Degeneration Market Size (2018-2029)
1.6.5 Middle East & Africa Age-related Macular Degeneration Market Size (2018-2029)
2 Age-related Macular Degeneration Market by Type
2.1 Introduction
2.1.1 Wet AMD
2.1.2 Dry AMD
2.2 Global Age-related Macular Degeneration Market Size by Type: 2018 VS 2022 VS 2029
2.2.1 Global Age-related Macular Degeneration Historic Market Size by Type (2018-2023)
2.2.2 Global Age-related Macular Degeneration Forecasted Market Size by Type (2024-2029)
2.3 Key Regions Market Size by Type
2.3.1 North America Age-related Macular Degeneration Revenue Breakdown by Type (2018-2029)
2.3.2 Europe Age-related Macular Degeneration Revenue Breakdown by Type (2018-2029)
2.3.3 Asia-Pacific Age-related Macular Degeneration Revenue Breakdown by Type (2018-2029)
2.3.4 Latin America Age-related Macular Degeneration Revenue Breakdown by Type (2018-2029)
2.3.5 Middle East and Africa Age-related Macular Degeneration Revenue Breakdown by Type (2018-2029)
3 Age-related Macular Degeneration Market Overview by Application
3.1 Introduction
3.1.1 Drugstore
3.1.2 Hospital
3.1.3 Others
3.2 Global Age-related Macular Degeneration Market Size by Application: 2018 VS 2022 VS 2029
3.2.1 Global Age-related Macular Degeneration Historic Market Size by Application (2018-2023)
3.2.2 Global Age-related Macular Degeneration Forecasted Market Size by Application (2024-2029)
3.3 Key Regions Market Size by Application
3.3.1 North America Age-related Macular Degeneration Revenue Breakdown by Application (2018-2029)
3.3.2 Europe Age-related Macular Degeneration Revenue Breakdown by Application (2018-2029)
3.3.3 Asia-Pacific Age-related Macular Degeneration Revenue Breakdown by Application (2018-2029)
3.3.4 Latin America Age-related Macular Degeneration Revenue Breakdown by Application (2018-2029)
3.3.5 Middle East and Africa Age-related Macular Degeneration Revenue Breakdown by Application (2018-2029)
4 Age-related Macular Degeneration Competition Analysis by Players
4.1 Global Age-related Macular Degeneration Market Size by Players (2018-2023)
4.2 Global Top Players by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Age-related Macular Degeneration as of 2022)
4.3 Date of Key Players Enter into Age-related Macular Degeneration Market
4.4 Global Top Players Age-related Macular Degeneration Headquarters and Area Served
4.5 Key Players Age-related Macular Degeneration Product Solution and Service
4.6 Competitive Status
4.6.1 Age-related Macular Degeneration Market Concentration Rate
4.6.2 Mergers & Acquisitions, Expansion Plans
5 Company (Top Players) Profiles
5.1 Bayer HealthCare
5.1.1 Bayer HealthCare Profile
5.1.2 Bayer HealthCare Main Business
5.1.3 Bayer HealthCare Age-related Macular Degeneration Products, Services and Solutions
5.1.4 Bayer HealthCare Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.1.5 Bayer HealthCare Recent Developments
5.2 F. Hoffmann-La Roche
5.2.1 F. Hoffmann-La Roche Profile
5.2.2 F. Hoffmann-La Roche Main Business
5.2.3 F. Hoffmann-La Roche Age-related Macular Degeneration Products, Services and Solutions
5.2.4 F. Hoffmann-La Roche Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.2.5 F. Hoffmann-La Roche Recent Developments
5.3 Novartis
5.3.1 Novartis Profile
5.3.2 Novartis Main Business
5.3.3 Novartis Age-related Macular Degeneration Products, Services and Solutions
5.3.4 Novartis Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.3.5 Regeneron Pharmaceuticals Recent Developments
5.4 Regeneron Pharmaceuticals
5.4.1 Regeneron Pharmaceuticals Profile
5.4.2 Regeneron Pharmaceuticals Main Business
5.4.3 Regeneron Pharmaceuticals Age-related Macular Degeneration Products, Services and Solutions
5.4.4 Regeneron Pharmaceuticals Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.4.5 Regeneron Pharmaceuticals Recent Developments
5.5 Alcon
5.5.1 Alcon Profile
5.5.2 Alcon Main Business
5.5.3 Alcon Age-related Macular Degeneration Products, Services and Solutions
5.5.4 Alcon Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.5.5 Alcon Recent Developments
5.6 Allergan
5.6.1 Allergan Profile
5.6.2 Allergan Main Business
5.6.3 Allergan Age-related Macular Degeneration Products, Services and Solutions
5.6.4 Allergan Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.6.5 Allergan Recent Developments
5.7 Avalanche
5.7.1 Avalanche Profile
5.7.2 Avalanche Main Business
5.7.3 Avalanche Age-related Macular Degeneration Products, Services and Solutions
5.7.4 Avalanche Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.7.5 Avalanche Recent Developments
5.8 Bausch+Lomb
5.8.1 Bausch+Lomb Profile
5.8.2 Bausch+Lomb Main Business
5.8.3 Bausch+Lomb Age-related Macular Degeneration Products, Services and Solutions
5.8.4 Bausch+Lomb Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.8.5 Bausch+Lomb Recent Developments
5.9 Gilead Sciences
5.9.1 Gilead Sciences Profile
5.9.2 Gilead Sciences Main Business
5.9.3 Gilead Sciences Age-related Macular Degeneration Products, Services and Solutions
5.9.4 Gilead Sciences Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.9.5 Gilead Sciences Recent Developments
5.10 Iconic Therapeutics
5.10.1 Iconic Therapeutics Profile
5.10.2 Iconic Therapeutics Main Business
5.10.3 Iconic Therapeutics Age-related Macular Degeneration Products, Services and Solutions
5.10.4 Iconic Therapeutics Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.10.5 Iconic Therapeutics Recent Developments
5.11 Neurotech Pharmaceuticals
5.11.1 Neurotech Pharmaceuticals Profile
5.11.2 Neurotech Pharmaceuticals Main Business
5.11.3 Neurotech Pharmaceuticals Age-related Macular Degeneration Products, Services and Solutions
5.11.4 Neurotech Pharmaceuticals Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.11.5 Neurotech Pharmaceuticals Recent Developments
5.12 Ohr Pharmaceutical
5.12.1 Ohr Pharmaceutical Profile
5.12.2 Ohr Pharmaceutical Main Business
5.12.3 Ohr Pharmaceutical Age-related Macular Degeneration Products, Services and Solutions
5.12.4 Ohr Pharmaceutical Age-related Macular Degeneration Revenue (US$ Million) & (2018-2023)
5.12.5 Ohr Pharmaceutical Recent Developments
6 North America
6.1 North America Age-related Macular Degeneration Market Size by Country (2018-2029)
6.2 U.S.
6.3 Canada
7 Europe
7.1 Europe Age-related Macular Degeneration Market Size by Country (2018-2029)
7.2 Germany
7.3 France
7.4 U.K.
7.5 Italy
7.6 Russia
7.7 Nordic Countries
7.8 Rest of Europe
8 Asia-Pacific
8.1 Asia-Pacific Age-related Macular Degeneration Market Size by Region (2018-2029)
8.2 China
8.3 Japan
8.4 South Korea
8.5 Southeast Asia
8.6 India
8.7 Australia
8.8 Rest of Asia-Pacific
9 Latin America
9.1 Latin America Age-related Macular Degeneration Market Size by Country (2018-2029)
9.2 Mexico
9.3 Brazil
9.4 Rest of Latin America
10 Middle East & Africa
10.1 Middle East & Africa Age-related Macular Degeneration Market Size by Country (2018-2029)
10.2 Turkey
10.3 Saudi Arabia
10.4 UAE
10.5 Rest of Middle East & Africa
11 Age-related Macular Degeneration Market Dynamics
11.1 Age-related Macular Degeneration Industry Trends
11.2 Age-related Macular Degeneration Market Drivers
11.3 Age-related Macular Degeneration Market Challenges
11.4 Age-related Macular Degeneration Market Restraints
12 Research Finding /Conclusion
13 Methodology and Data Source
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Disclaimer
13.4 Author List
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
